Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01591304 · ClinicalTrials.gov registry record · NA
Feasibility Study: Ulthera® System for the Treatment of Moderate to Severe Facial Acne
A NA study, sponsored by Ulthera.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT01591304: Completed NA study, sponsored by Ulthera.
NCT01591304 is a NA study that has completed, run by Ulthera. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01591304, a NA study, has completed, sponsored by Ulthera.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of Ultherapy for the treatment of facial acne.
Primary Outcome
Determined by a reduction in inflammatory and non-inflammatory lesion counts from baseline.
Interventions
- DEVICE Ulthera System Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2011-08 |
| Est. Completion | 2014-07 |
| Phase | NA |
What the finished NCT01591304 record still lists
NCT01591304 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Ulthera System Treatment is the first listed.
NCT01591304 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01591304 about?
NCT01591304 is a clinical study titled "Feasibility Study: Ulthera® System for the Treatment of Moderate to Severe Facial Acne". This study will evaluate the effectiveness of Ultherapy for the treatment of facial acne.
What is the current status of trial NCT01591304?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2011-08. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01591304?
The interventions under investigation include: Ulthera System Treatment (DEVICE).
Who is sponsoring clinical trial NCT01591304?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01591304's enrollment target sits among peer trials
24 1736th of 2000 higher than 246 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia